Recently, the U.S. Food and Drug Administration (FDA) approved updated flu and COVID-19 vaccines, and leading medical societies released new recommendations for respiratory vaccines, including COVID-19, flu, and RSV. Given these developments, consumers may have questions regarding insurance coverage, which vaccines are recommended for them, where to access vaccines, and what barriers they may encounter.
CVEEP hosted a webinar on what to know about the current status of respiratory vaccines and availability across the country. Experts in vaccine policy, health insurance, and pharmacy access discussed the latest recommendations for respiratory vaccines and what consumers need to know.
Panelists included:
Older adults are at increased risk for serious illness from infectious diseases like COVID-19, flu, RSV, pneumococcal disease, and shingles. Aging naturally weakens the immune system, and chronic health conditions become more common over time. This makes it harder for the body to fight off infections and can lead to longer recovery times, and a higher likelihood of hospital stays. Staying up to date on recommended vaccines is an important step that older adults can take to help protect and maintain their health and independence.
In recognition of Older Americans Month, CVEEP held a webinar highlighting the role vaccines play in helping protect adults from severe illness. Experts in vaccines and aging provided information on why older adults are at increased risk for severe outcomes, which vaccines are recommended based on age and health status, and where to access them. Speakers also offered practical guidance for older adults and caregivers on how to have informed conversations with healthcare providers and steps to stay up to date on vaccines.
Panelists included: